1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-Aged individuals
- Contribution to journal › Article
- 2023
-
Mark
Elevated low-density lipoprotein cholesterol : An inverse marker of morbidity and mortality in patients with myocardial infarction
- Contribution to journal › Article
- 2021
-
Mark
Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes : A Swedish nationwide cohort study
- Contribution to journal › Article